Washington, D.C. 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

Commission File No.  0-10783

(Check one): [   ] Form 10-K [   ] Form 20-F [X] Form 10-Q [   ] Form N-SAR 
             [   ] Form N-CSR

                  For Period Ended:  November 30, 2005
                  [   ] Transition Report on Form 10-K
                  [   ] Transition Report on Form 20-F
                  [   ] Transition Report on Form 11-K
                  [   ] Transition Report on Form 10-Q
                  [   ] Transition Report on Form N-SAR
                  [   ] Transition Report on Form N-CSR
                  For the Transition Period Ended:

Nothing  in this  form  shall be  construed  to imply  that the  Commission  has
verified any information contained herein.

If the notification  relates to a portion of the filing checked above,  identify
the Item(s) to which the notification relates: N/A


Full Name of Registrant:  BSD Medical Corporation
Former Name if Applicable:  N/A
Address of Principal Executive Office (Street and Number):  2188 West 2200 South
City, State and Zip Code:  Salt Lake City, Utah  84119

PART II-- RULES 12b-25(b) AND (c)

If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

         (a)  The reason described in reasonable detail in Part III of this form
              could not be eliminated without unreasonable effort or expense
         (b)  The subject annual report,  semi-annual report,  transition report
              on Form 10-K,  Form 20-F,  Form 11-K, Form N-SAR or Form N-CSR, or
  [X]         portion thereof, will be filed on or before the fifteenth calendar
              day following the  prescribed  due date; or the subject  quarterly
              report or transition report on Form l0-Q, or portion thereof, will
              be filed  on or  before  the  fifth  calendar  day  following  the
              prescribed due date; and
         (c)  The  accountant's  statement  or other  exhibit  required  by Rule
              12b-25(c) has been attached if applicable.



State below in reasonable detail why forms 10-K, 20-F, 11-K, 10-Q, N-SAR, N-CSR,
or the  transition  report or  portion  thereof,  could not be filed  within the
prescribed time period.

BSD Medical Corporation was prepared to file its Quarterly Report on Form 10-QSB
(the  "Report")  on a timely basis but  experienced  technical  difficulties  in
connection with  transmitting  written  authorization to its outside provider to
submit the  Report on Edgar.  As a result,  the  Report was filed  approximately
seventeen (17) minutes past the deadline for filing on January 17, 2006.


(1)   Name  and  telephone  number  of  person  to  contact  in  regard  to this

              Dennis Bradley               (801)                  972-5555
              --------------               -----                  --------
                  (Name)                (Area Code)          (Telephone Number)

(2)   Have all other periodic  reports required under Section 13 or 15(d) of the
      Securities  Exchange Act of 1934 or Section 30 of the  Investment  Company
      Act of 1940 during the  preceding 12 months (or for such  shorter)  period
      that the registrant  was required to file such  report(s)  been filed?  If
      answer is no, identify report(s). Yes [X] No [ ]

(3)   Is it  anticipated  that any  significant  change in results of operations
      from the  corresponding  period for the last fiscal year will be reflected
      by the earnings statements to be included in the subject report or portion
      thereof? Yes [ ] No [X]

If so, attach an explanation of the  anticipated  change,  both  narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.


                             BSD Medical Corporation
                  (Name of Registrant as Specified in Charter)

has  caused  this  notification  to be signed on its  behalf by the  undersigned
hereunto duly authorized.

Date: January 18, 2006               By     /s/ Dennis Bradley  
                                          Name: Dennis Bradley
                                          Title:   Principal Financial Officer

Instruction:  This form may be signed by an executive  officer of the registrant
or by any other duly authorized representative. The name and title of the person
signing  the form  shall  be typed or  printed  beneath  the  signature.  If the
statement is signed on behalf of the registrant by an authorized  representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.